TrialGynecologic oncology2021

Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).

Megan E Buechel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.